Sera Prognostics Inc., a Salt Lake City-based company focused on improving maternal and neonatal health through innovative precision biomarker approaches, has appointed Dr. Thomas J. Garite as vice president of clinical sciences. Garite will work closely with Sera to advance clinical development programs that support the company’s growth from development into a commercial-stage company. Garite is an expert in obstetrics and gynecology and maternal-fetal medicine and a recently retired Edward H. Quilligan Professor of Obstetrics and Gynecology at the University of California at Irvine. Garite served 18 years as the department’s chairman, and now holds the title of Professor Emeritus. He is also the past editor-in-chief of the American Journal of Obstetricians and Gynecology and remains Editor Emeritus. Until recently, Garite served as director of research and education for Obstetrix, MedNax Medical Group. He currently serves as chief clinical officer for patient safety company Perigen Inc.